abstract |
.The invention concerns the use of proteins comprising or consisting of the sequences SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6 or SEQ ID NO: 7, for preparing medicines for treating diseases related to oxidative stress or to endoplasmic reticulum stress, or neurodegenerative disorders, in particular retinal. |